Rhythm Biosciences Ltd. ( (AU:RHY) ) has shared an announcement.
FIL Limited has become a substantial holder in Rhythm Biosciences Ltd., acquiring a 5.04% voting power through significant stock purchases. This acquisition of 14,595,477 shares highlights FIL Limited’s strategic interest in Rhythm Biosciences, potentially influencing its operations and market dynamics.
More about Rhythm Biosciences Ltd.
YTD Price Performance: -3.33%
Average Trading Volume: 425,125
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$24.95M
For a thorough assessment of RHY stock, go to TipRanks’ Stock Analysis page.